Has Edward Haight, MD received payments from drug or device companies?

Yes. Drug and device makers reported $26,106 in general payments to Edward Haight, MD across 1,393 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Edward Haight, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Edward Haight, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Edward Haight, MD

Neurology · Gray, LANPI 1972509818

Payments from drug & device makers

$26,106in general payments, 2019–2025

Across 1,393 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Acadia Pharmaceuticals Inc$2K
UCB, Inc.$2K
Eisai Inc.$1K
CSL Behring$1K
Amgen$1K
plus $17K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	140	$1,787
Acadia Pharmaceuticals Inc	91	$1,713
UCB, Inc.	77	$1,608
Eisai Inc.	62	$1,303
CSL Behring	53	$1,268
Amgen(2 entities)	63	$1,259
Lilly USA, LLC	60	$1,201
Biogen	55	$1,058
Novartis	58	$1,040
Teva Pharmaceuticals USA, Inc.	58	$1,031
SK Life Science, Inc.	44	$834
Sunovion Pharmaceuticals Inc.	48	$821
Neurocrine Biosciences, Inc.	43	$741
Lundbeck LLC	32	$728
Jazz Pharmaceuticals Inc.	30	$653
Pfizer	34	$646
Bristol Myers Squibb	26	$616
MDD US Operations, LLC	31	$574
EMD Serono, Inc.	31	$552
Sanofi	25	$514
Upsher-smith Laboratories LLC	32	$508
Kyowa Kirin, Inc.	22	$490
Axsome Therapeutics, Inc.	17	$414
Acorda Therapeutics, Inc	16	$312
Supernus Pharmaceuticals, Inc.	24	$300
AstraZeneca	16	$281
Sumitomo Pharma America, Inc.	24	$275
Arbor Pharmaceuticals, Inc.	13	$236
GE HealthCare	10	$232
Avanir Pharmaceuticals, Inc.	12	$225
Biohaven Pharmaceuticals, Inc.	8	$196
Otsuka America Pharmaceutical, Inc.	9	$187
Biohaven Pharmaceutical Holding Company Ltd.	11	$175
Grifols USA, LLC	8	$162
Catalyst Pharmaceuticals, Inc.	7	$155
Johnson & Johnson	11	$150
Medtronic	4	$150
ANI Pharmaceuticals, Inc.	8	$139
E.r. Squibb & Sons, L.L.C.	8	$137
Promius Pharma LLC	5	$112
Forte Bio-pharma LLC	4	$110
Alfasigma USA, Inc.	5	$106
Genentech USA, Inc.	7	$105
Neurelis, Inc.	5	$105
Sentynl Therapeutics, Inc.	5	$86
Argenx US, Inc.	4	$81
Takeda Pharmaceuticals U.S.A., Inc.	3	$71
Ipsen Biopharmaceuticals, Inc	3	$60
Banner Life Sciences, LLC	2	$45
Amneal Pharmaceuticals LLC	2	$42
Tanabe Pharma America, Inc.	2	$39
Boston Scientific	2	$39
Merz Pharmaceuticals, LLC	2	$38
TG Therapeutics, Inc.	2	$35
Mallinckrodt Hospital Products Inc.	1	$34
Azurity Pharmaceuticals, Inc.	2	$30
Merck	2	$29
Vanda Pharmaceuticals Inc.	1	$26
Sanofi-aventis U.S. LLC	1	$24
Xeris Pharmaceuticals, Inc.	1	$24

How this compares

$26,106 in reported general payments places this provider in the 85th percentile of 225 neurology providers in Louisiana.

See all neurology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$517,640

Medicare patients

850

Services billed

14,570

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Gray

Donald GervaisGray$125K
Ariel Antezana AntezanaAlexandria$2.5M
Jon OlsonBaton Rouge$1.7M
Bridget BagertNew Orleans$1.4M
Carol RedillasChalmette$1.3M
Joseph TarsiaNew Orleans$1.2M
Angela TraylorNew Orleans$941K
Meghan HarrisShreveport$698K
Maria Carmen WilsonCovington$681K
Kevin CallerameBaton Rouge$420K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →